To further investigate the role of CD36 on VM-competent melanoma cells, we performed inverse invasion assays wherein we tested the ability of C32 melanoma cells (without or with CD36) to crawl through an extracellular matrix (Matrigel) towards a chemoattractant (10% FBS). This evidence concerns the gene CD36 and melanoma.